BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34599569)

  • 1. Evaluating the accuracy of three international guidelines in identifying the risk of malignancy in pancreatic cysts: a retrospective analysis of a surgical treated population.
    Vanden Bulcke A; Jaekers J; Topal H; Vanbeckevoort D; Vandecaveye V; Roskams T; Weynand BA; Dekervel J; Van Cutsem E; van Malenstein H; Verslype C; Laleman W; van der Merwe S
    Acta Gastroenterol Belg; 2021; 84(3):443-450. PubMed ID: 34599569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome.
    Lekkerkerker SJ; Besselink MG; Busch OR; Verheij J; Engelbrecht MR; Rauws EA; Fockens P; van Hooft JE
    Gastrointest Endosc; 2017 May; 85(5):1025-1031. PubMed ID: 27693645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the diagnostic accuracy of three current guidelines for the evaluation of asymptomatic pancreatic cystic neoplasms.
    Xu MM; Yin S; Siddiqui AA; Salem RR; Schrope B; Sethi A; Poneros JM; Gress FG; Genkinger JM; Do C; Brooks CA; Chabot JA; Kluger MD; Kowalski T; Loren DE; Aslanian H; Farrell JJ; Gonda TA
    Medicine (Baltimore); 2017 Sep; 96(35):e7900. PubMed ID: 28858107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria.
    Sighinolfi M; Quan SY; Lee Y; Ibaseta A; Pham K; Dua MM; Poultsides GA; Visser BC; Norton JA; Park WG
    Dig Dis Sci; 2017 Mar; 62(3):626-632. PubMed ID: 28116593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements.
    Dbouk M; Brewer Gutierrez OI; Lennon AM; Chuidian M; Shin EJ; Kamel IR; Fishman EK; He J; Burkhart RA; Wolfgang CL; Hruban RH; Goggins MG; Canto MI
    Pancreatology; 2021 Apr; 21(3):613-621. PubMed ID: 33593706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data.
    Singhi AD; Zeh HJ; Brand RE; Nikiforova MN; Chennat JS; Fasanella KE; Khalid A; Papachristou GI; Slivka A; Hogg M; Lee KK; Tsung A; Zureikat AH; McGrath K
    Gastrointest Endosc; 2016 Jun; 83(6):1107-1117.e2. PubMed ID: 26709110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing American Gastroenterological Association Pancreatic Cyst Management Guidelines with Fukuoka Consensus Guidelines as Predictors of Advanced Neoplasia in Patients with Suspected Pancreatic Cystic Neoplasms.
    Ma GK; Goldberg DS; Thiruvengadam N; Chandrasekhara V; Kochman ML; Ginsberg GG; Vollmer CM; Ahmad NA
    J Am Coll Surg; 2016 Nov; 223(5):729-737.e1. PubMed ID: 27497827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sendai and Fukuoka Consensus Guidelines Identify Advanced Neoplasia in Patients With Suspected Mucinous Cystic Neoplasms of the Pancreas.
    Kaimakliotis P; Riff B; Pourmand K; Chandrasekhara V; Furth EE; Siegelman ES; Drebin J; Vollmer CM; Kochman ML; Ginsberg GG; Ahmad NA
    Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1808-15. PubMed ID: 25818077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of AGA and Fukuoka Guidelines for EUS and surgical resection of incidental pancreatic cysts.
    Lee A; Kadiyala V; Lee LS
    Endosc Int Open; 2017 Feb; 5(2):E116-E122. PubMed ID: 28210708
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines.
    Smith AL; Abdul-Karim FW; Goyal A
    Cancer Cytopathol; 2016 Apr; 124(4):285-93. PubMed ID: 26618476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Economic Outcomes of Patients Undergoing Guideline-Directed Management of Pancreatic Cysts.
    Lobo JM; Scheiman JM; Zaydfudim VM; Shami VM; Sauer BG
    Am J Gastroenterol; 2020 Oct; 115(10):1689-1697. PubMed ID: 32558682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas.
    Sawhney MS; Al-Bashir S; Cury MS; Brown A; Chuttani R; Pleskow DK; Callery MP; Vollmer CM
    Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1373-6. PubMed ID: 19577006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the clinical utility of 4 guidelines in the initial triage of mucinous cystic lesions of the pancreas based on cross-sectional imaging: Experience with 188 surgically-treated patients.
    Park RHS; Lim GRS; Wu JJY; Koh YX; Teo JY; Cheow PC; Chan CY; Ooi LLPJ; Chung AYF; Goh BKP
    Eur J Surg Oncol; 2020 Nov; 46(11):2114-2121. PubMed ID: 32828582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of Sendai and Fukuoka consensus guidelines in predicting malignancy in patients with preoperatively diagnosed mucinous pancreatic cystic neoplasms.
    Zhou W; Xu Y; Rong Y; Wu W; Kuang T; Xin B; Zhu H; Lou W; Wang D
    J Surg Oncol; 2018 Mar; 117(3):409-416. PubMed ID: 29044541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of Fukuoka and American Gastroenterological Association Guidelines for Predicting Advanced Neoplasia in Pancreatic Cyst Neoplasm: A Meta-Analysis.
    Wu J; Wang Y; Li Z; Miao H
    Ann Surg Oncol; 2019 Dec; 26(13):4522-4536. PubMed ID: 31617119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms.
    Mukewar S; de Pretis N; Aryal-Khanal A; Ahmed N; Sah R; Enders F; Larson JJ; Levy MJ; Takahashi N; Topazian M; Pearson R; Vege SS; Chari ST
    Gut; 2017 Oct; 66(10):1811-1817. PubMed ID: 27390303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of integrated molecular pathology test results on real-world management decisions for patients with pancreatic cysts: analysis of data from a national registry cohort.
    Loren D; Kowalski T; Siddiqui A; Jackson S; Toney N; Malhotra N; Haddad N
    Diagn Pathol; 2016 Jan; 11():5. PubMed ID: 26790950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of cyst size and tumor markers in the management of pancreatic cysts: support for the original Sendai criteria.
    Hoffman RL; Gates JL; Kochman ML; Ginsberg GG; Ahmad NA; Chandrasekhara V; Furth EE; Vollmer CM; Drebin JA
    J Am Coll Surg; 2015 Jun; 220(6):1087-95. PubMed ID: 25868415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Patients With Pancreatic Cysts: Analysis of Possible False-Negative Cases of Malignancy.
    Kowalski T; Siddiqui A; Loren D; Mertz HR; Mallat D; Haddad N; Malhotra N; Sadowski B; Lybik MJ; Patel SN; Okoh E; Rosenkranz L; Karasik M; Golioto M; Linder J; Catalano MF; Al-Haddad MA
    J Clin Gastroenterol; 2016 Sep; 50(8):649-57. PubMed ID: 27332745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of commercial DNA analysis in detecting malignancy within pancreatic cysts.
    Lee LS; Wu BU; Banks PA; Kadiyala V; Mehta S; Saltzman JR; Thompson CC; Bellizzi AM
    JOP; 2013 Mar; 15(2):182-8. PubMed ID: 24618422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.